1. Home
  2. EQS vs ALUR Comparison

EQS vs ALUR Comparison

Compare EQS & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

HOLD

Current Price

$1.31

Market Cap

18.9M

Sector

Finance

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.73

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQS
ALUR
Founded
1991
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
18.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EQS
ALUR
Price
$1.31
$1.73
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.25
AVG Volume (30 Days)
24.9K
77.4K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,377,000.00
$17,208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.47
P/E Ratio
N/A
N/A
Revenue Growth
21.11
N/A
52 Week Low
$0.74
$1.02
52 Week High
$2.49
$16.81

Technical Indicators

Market Signals
Indicator
EQS
ALUR
Relative Strength Index (RSI) 25.99 59.17
Support Level $1.27 $1.18
Resistance Level $1.44 $1.91
Average True Range (ATR) 0.13 0.14
MACD -0.03 0.05
Stochastic Oscillator 9.32 79.37

Price Performance

Historical Comparison
EQS
ALUR

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: